• CONTACT
• NEWS & EVENTS
• RESEARCH & PUBLICATIONS
• NETWORK
• BUSINESS
• COMPANY

  BMSystems value Generation

• BMSystems is a research-based biotech company that creates CADI™ models to generate businesses with immediate applications through contract or collaborative research programs.
• BMSystems does not sell its technologies nor access to its technologies, but collaborates with its clients under adapted contract frameworks to suite their requirements.
• BMSystems, thanks to its collaborative strategy, can also address with limited marketing costs, all the markets (biomedical,chemistry, energy, environment, etc…) where its CADI™ models generate strong competitive advantages for its partners.

Technology Developments (know-how, patents)

• CADI™ Know-how and Tools
• TAPE patent (WO/2008/093010) December 2006
• AB-ACCUS patent (WO/2008/093009) December 2006
• RiPh patent May 2009
• CNS (psychiatric disorders) new therapeutic strategies and preclinical evaluation platform patent,  filed with CEA Life Sciences (September 10, 2008)

Contract Research (fees and possible royalties)

• Pharma (confidential)
• Chemical Industry (confidential)
• Environment / Energy

Consortiums / J.V. (fees, royalties)

• Synthons program: Major Industrial biotech research platform, in partnership with ARD, IBT
• Industrial partners (L’Oréal, Arkema, Rhodia)
• BioXplain: The first Open Platform for Iterative Predictive and Integrative Biology  / Systems Biology with Kayentis and BioXpr

Spin-Offs (equity, fees, royalties)

• Pherecydes-Pharma. Our first spin-off company in the fields of BioDefense and BioSecurity developed from our CADI™ outputs (TAPE, AB-ACCUS). Pherecydes Pharma S.A. (anti-bacterial bio-agents) was incorporated and financed on December 20, 2006.
• New project initiated for a Newco

BMSystems: a leading Systems Biology / Integrative Biology company that delivers
Copyright © 2010 Bio-Modeling Systems / bioModeling Systems / BMSystems. All rights reserved bmsystems(at)bmsystems.net or biomodeling(at)bmsystems.net